BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25336085)

  • 1. Efficacy and safety of pharmacological treatments for neuroborreliosis--protocol for a systematic review.
    Dersch R; Freitag MH; Schmidt S; Sommer H; Rücker G; Rauer S; Meerpohl JJ
    Syst Rev; 2014 Oct; 3():117. PubMed ID: 25336085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review.
    Dersch R; Freitag MH; Schmidt S; Sommer H; Rauer S; Meerpohl JJ
    Eur J Neurol; 2015 Sep; 22(9):1249-59. PubMed ID: 26058321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocol.
    Torbahn G; Hofmann H; Allert R; Freitag MH; Dersch R; Fingerle V; Sommer H; Motschall E; Meerpohl JJ; Schmucker C
    Syst Rev; 2016 May; 5():73. PubMed ID: 27142846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis in children: a systematic review.
    Dersch R; Hottenrott T; Schmidt S; Sommer H; Huppertz HI; Rauer S; Meerpohl JJ
    BMC Neurol; 2016 Sep; 16(1):189. PubMed ID: 27686962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis: An updated systematic review.
    Dersch R; Rauer S
    Eur J Neurol; 2023 Dec; 30(12):3780-3788. PubMed ID: 37565386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroborreliosis - Diagnostics, treatment and course].
    Dersch R; Rauer S
    Nervenarzt; 2017 Apr; 88(4):419-431. PubMed ID: 28175945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The facial nerve palsy and cortisone evaluation (FACE) study in children: protocol for a randomized, placebo-controlled, multicenter trial, in a Borrelia burgdorferi endemic area.
    Karlsson S; Arnason S; Hadziosmanovic N; Laestadius Å; Hultcrantz M; Marsk E; Skogman BH
    BMC Pediatr; 2021 May; 21(1):220. PubMed ID: 33947355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial.
    Solheim AM; Ljøstad U; Mygland Å
    BMJ Open; 2019 Jun; 9(6):e027083. PubMed ID: 31201188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy).
    Bremell D; Hagberg L
    BMC Infect Dis; 2011 Aug; 11():215. PubMed ID: 21831262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyme Neuroborreliosis.
    Rauer S; Kastenbauer S; Fingerle V; Hunfeld KP; Huppertz HI; Dersch R
    Dtsch Arztebl Int; 2018 Nov; 115(45):751-756. PubMed ID: 30573008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular Events in Lyme Neuroborreliosis.
    Wittwer B; Pelletier S; Ducrocq X; Maillard L; Mione G; Richard S
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1671-8. PubMed ID: 26002071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Halperin JJ; Shapiro ED; Logigian E; Belman AL; Dotevall L; Wormser GP; Krupp L; Gronseth G; Bever CT;
    Neurology; 2007 Jul; 69(1):91-102. PubMed ID: 17522387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pain and neuroborreliosis: significance, diagnosis and treatment].
    Rupprecht TA; Birnbaum T; Pfister HW
    Schmerz; 2008 Oct; 22(5):615-23. PubMed ID: 18688658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lyme borreliosis and Lyme neuroborreliosis - an update].
    Dersch R; Fingerle V
    Dtsch Med Wochenschr; 2021 Jun; 146(11):728-732. PubMed ID: 34062587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.
    Pfister HW; Rupprecht TA
    Int J Med Microbiol; 2006 May; 296 Suppl 40():11-6. PubMed ID: 16524775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network meta-analysis of randomised trials of pharmacological, psychotherapeutic, exercise and collaborative care interventions for depressive symptoms in patients with coronary artery disease: hybrid systematic review of systematic reviews protocol.
    Doyle F; Freedland K; Carney R; de Jonge P; Dickens C; Pedersen S; Sorensen J; Dempster M
    Syst Rev; 2019 Mar; 8(1):71. PubMed ID: 30878039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.
    Skogman BH; Croner S; Nordwall M; Eknefelt M; Ernerudh J; Forsberg P
    Pediatr Infect Dis J; 2008 Dec; 27(12):1089-94. PubMed ID: 19008771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of hemifacial paresis in a patient with Lyme neuroborreliosis treated with antibiotics in whom Borrelia meningitis developed].
    Shimizu H; Haratani K; Miyazaki M; Kakehi Y; Nagami S; Katanami Y; Kawabata H; Takahashi N
    Rinsho Shinkeigaku; 2016 Jul; 56(7):495-8. PubMed ID: 27356734
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.